QR-Code

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

Abstract Background Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the antithrombotic prescription patterns for Chinese patients enrolled post-d...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Xiaoxia Liu, Guoze Feng, Sabrina Vogel Marler, Menno V Huisman, Gregory Y. H. Lip, Changsheng Ma
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2023-08-01
Schriftenreihe:Thrombosis Journal
Schlagworte:
Atrial fibrillation
Oral anticoagulation
Stroke
Prevention
China
Online-Zugang:https://doi.org/10.1186/s12959-023-00527-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge